Ledger.Open graph →
SEC Form D · filed July 11, 2022

Thetis Pharmaceuticals LLC

Offering
$2.0M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Ridgefield, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Gary Mathias · Ridgefield, CTExec · DirectorFrank C. Sciavolino · Quaker Hill, CTDirectorDennis F. Willson · Rancho Sante Fe, CADirectorWalter Ogier · Boston, MADirectorCynthia F. Green · New Haven, CTDirectorGary Mathias · Branford, CTExec · DirectorFrank C. Sciavolino · Waterford, CTDirectorWalter Ogier · Cambridge, MADirectorCynthia F. Green · New Haven, CTDirectorDennis F. Willson · Rancho Sante Fe, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗